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Abstract
Individualized treatments with combination of radiotherapy and targeted drugs require knowledge about the behavior
of molecular targets after irradiation. Angiogenic marker expression has been studied after conventional radiotherapy,
but little is known about marker response to charged particles. For the very first time, we used molecular ultrasound
imaging to intraindividually track changes in angiogenic marker expression after carbon ion irradiation in experimental
tumors. Expression of intercellular adhesion molecule-1 (ICAM-1) and of αvβ3-integrin in subcutaneous AT-1 prostate
cancers in rats treated with carbon ions (16 Gy) was studied using molecular ultrasound and immunohistochemistry.
For this purpose, cyanoacrylate microbubbles were synthesized and linked to specific ligands. The accumulation of
targetedmicrobubbles in tumorswas quantified before and 36 hours after irradiation. In addition, tumor vascularization
was analyzed using volumetric Doppler ultrasound. In tumors, the accumulation of targeted microbubbles was signifi-
cantly higher than in nonspecific ones and could be inhibited competitively. Before irradiation, no difference in binding
of αvβ3-integrin–specific or ICAM-1–specific microbubbles was observed in treated and untreated animals. After irra-
diation, however, treated animals showed a significantly higher binding of αvβ3-integrin–specific microbubbles and an
enhanced binding of ICAM-1–specific microbubbles than untreated controls. In both groups, a decrease in vasculari-
zation occurred during tumor growth, but no significant differencewas observed between irradiated and nonirradiated
tumors. In conclusion, carbon ion irradiationupregulates ICAM-1 andαvβ3-integrin expression in tumor neovasculature.
Molecular ultrasound can indicate the regulation of thesemarkers and thusmay help to identify the optimal drugs and
time points in individualized therapy regimens.
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Introduction
The recent development of novel antiangiogenic drugs holds great
promise for cancer treatment [1]. In previous studies, we and others
have shown that radiotherapy can be beneficially combined with in-
hibitors for vascular endothelial growth factor/platelet-derived growth
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factor signaling [2,3] or inhibitors of αvβ3-integrin signaling [4]. The
beneficial combination might be caused in part by the up-regulation of
receptor molecules for proangiogenic factors including vascular endo-
thelial growth factor or basic fibroblast growth factor after irradiation
and the subsequent inhibitory effects of the drugs [5]. Likewise, it is
known that irradiation induces expression of αvβ3-integrin in human
endothelium in vitro [4] and in the endothelium of tumor vessels [6]. It
is conceivable that the increased level of target receptors after radiation,
therefore, might even boost the effects of targeted therapy approaches
(e.g., humanized monoclonal antibody therapies directed against αvβ3-
integrin; EMD 121974 [7]) if administered during the highest level of
marker expression; however, the ideal way of using this potentially pow-
erful combination of time optimized drug administration concurrently
or after irradiation has yet to be determined, particularly with regard to
dose- and time-dependent marker up-regulation. Thus, the ability to
noninvasively quantify the modulation of target receptors after irradia-
tion would enable adaptation of the targeted drug regimen to the indi-
vidual molecular tumor profile of a patient.
Several imaging modalities such as positron emission tomography,
single photon emission computed tomography, and optical techniques
can be used to assess the expression of angiogenic marker molecules
such as αvβ3-integrin [8–10]. However, their expense, availability, and
ionizing radiation limit patient accessibility. In contrast, ultrasound is
the most widely used imaging technique, is inexpensive, is portable,
and provides noninvasive real-time imaging. In addition, ultrasound
has proven to be highly sensitive for the identification of molecular
structures when using targeted contrast agents [11,12]. Ultrasound
contrast agents consist of stabilized bubbles with a diameter between
1 and 5 μm. Because of their size, they behave hemodynamically like
red blood cells and can be directed selectively to specific vascular beds
by conjugating targeting ligands (peptides and antibodies) to their
surface [13]. In this regard, molecular imaging using targeted micro-
bubbles has been used in vivo to assess inflammation, angiogenesis,
and thrombus formation [13]. Recently, it was reported that volumetric
molecular ultrasound imaging can be used to depict changes in the
molecular profile of tumors during untreated growth or antiangiogenic
therapy [14].
Whereas the effects of conventional photon irradiation using low
linear energy transfer (LET) beams has been studied in a variety of
models, little is known about the effects of high LET radiation using
charged particles. These high LET beams combine an excellent physi-
cal depth-dose profile with an increased relative biologic effectiveness in
the target volume. Molecular and cellular mechanisms underlying this
increased relative biologic effectiveness are still under investiga-
tion [15,16]. This question is important because several large facilities
worldwide will open their clinical program in the coming months or
years. One of these facilities will be the heavy ion therapy facility in
Heidelberg, Germany, where carbon ion beams will be used for clinical
patient treatments (expected >1000 patients per year).
Because very little is known about the impact of carbon ions on the
tumor endothelium under in vivo conditions, we investigated the po-
tential of three-dimensional molecular ultrasound imaging in assess-
ing changes in the expression of the angiogenic marker αvβ3-integrin
and of the inflammatory marker intercellular adhesion molecule-1
(ICAM-1) in experimental prostate carcinomas in rats after carbon ion
therapy. The results were compared with immunohistologic staining
and correlated with the changes in tumor vascularization measured by
high-frequency power Doppler ultrasound. From this study, we con-
clude that molecular ultrasound imaging using targeted microbubbles
could be used for noninvasive characterization of tumor angiogenesis
and assessment of vascular expression of molecular markers after radia-
tion therapy.
Materials and Methods
Preparation of Target-Specific Microbubbles
Air-filled streptavidin-coated cyanoacrylate microbubbles were
custom made as described previously [17]. The target specificity of
streptavidin-coated microbubbles was generated immediately before
their use by adding either 10 μg of biotinylated antirat–ICAM-1 anti-
bodies (Pharmingen, Heidelberg, Germany) or 5 μg of biotinylated
RGD peptides (Peptides International, Louisville, KY; both diluted
in 50 μl of phosphate-buffered saline) to 250 μl of microbubble sus-
pension (108 microbubbles per milliliter). Reagents were allowed to
react for 5 minutes at 20°C, resulting in a 300-μl injection volume con-
taining 2.5 × 107 target-specific microbubbles.
Tumor Model and Therapy Regime
All experiments were approved by the governmental review com-
mittee on animal care. The Dunning prostate cancer of rats was chosen
as the tumor model [18]. The AT-1 subline used in this study forms
anaplastic hormone-independent tumors without glandular differ-
entiation. A total of eight adult male Copenhagen rats (body weight,
∼180-200 g) were included in the study. AT-1 tumors were inoculated
subcutaneously in both hind legs using fragments of donor tumors.
Carbon ion irradiation was performed at the heavy ion accelerator of
the “Gesellschaft für Schwerionenforschung” in Darmstadt, Germany.
An intensity-controlled raster scanner was used to shape the irradia-
tion fields. A total of seven tumor-bearing animals were treated with
a 16-Gy single dose of 12C ions. Treatment was constraint to tumors
growing in the distal right thigh, whereas the contralateral tumors served
as sham-treated controls. During irradiation, animals were positioned
on a specially designed rack and maintained under inhalation anesthesia
using oxygen and 2.5 vol% sevoflurane. One animal (the nonirradiated
one) was used to verify the specificity of antibody- or RGD peptide–
conjugated microbubbles. The remaining seven animals were used to
investigate the therapeutic effects of carbon ions, either by imaging
(n = 4) or by immunohistochemistry (n = 3).
Tumor Vascularization Assessed by Three-dimensional
High-Frequency Doppler Ultrasound
Ultrasound measurements were performed 36 hours before and
36 hours after carbon ion therapy using the VEVO770microultrasound
system (VisualSonics, Toronto, Canada) equipped with the RMV-704
ultrasound probe (Doppler frequency, 30 MHz). For ultrasound ex-
amination, the rats were anesthetized by inhaling a mixture of isoflurane
(1.5%) and oxygen (98.5%). The anesthetized animals were placed on
an examination table, and the tumors were covered with ultrasound
gel. An ultrasound transducer, fixed on a motor-driven unit above the
animal, moved perpendicular to the beam axis, thereby acquiring
consecutive images in power Doppler mode with a slice thickness of
200 μm. A region of interest (ROI) was drawn within every two-
dimensional image. Finally, the two-dimensional ultrasound images
were reconstructed to a three-dimensional data set. The vascularization
within the tumor (determined as percentage of power Doppler–derived
color pixels) was measured. Intraindividual changes measured before
and after therapy were expressed as change in percentage (%).
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Assessment of Marker Expression Using Molecular
Ultrasound Imaging
The same animals (n = 4) were then examined by the three-
dimensional quantitative molecular ultrasound technique known as
sensitive particle acoustic quantification (SPAQ) [19]. A catheter was
placed in the tail vein to enable intravenous injections, and the anesthe-
tized animal was fixed on a gel pad (Figure 1). The tumors, implanted
subcutaneously on both hind legs, were positioned downwards, start-
ing with the right side. The pad was placed on a navigable motor-table
that could be moved in steps of micrometers over a fixed ultrasound
transducer (Sector-Scanner S12, Sonos 5500; Philips Medical Systems,
Andover, MA). Unspecific microbubbles were injected intravenously
through a tail-vein catheter. Subsequently, saline was injected to clear
the catheter from microbubbles. Volumetric imaging was performed
7 minutes after microbubble administration, following a previous study
in which timing parameters had been optimized [17]. The initial ultra-
sound scan of the whole tumor volume was followed by three control
scans to ensure that no intact microbubbles remained within the tumor.
Imaging took in total less than 2 minutes. Subsequently, the animal was
turned around to examine the tumor on the left hind leg, without
further administration of microbubbles. After this procedure, RGD-
conjugated microbubbles were injected, and the animal was scanned
with the identical protocol. Subsequently, the same amount of anti–
ICAM-1 antibody–conjugated microbubbles was administered. Thirty-
six hours after imaging, tumors implanted on the right hind leg were
treated with carbon ions as described above. Thirty-six hours after radia-
tion, animals were examined again with an identical protocol.
For postprocessing, a ROI was drawn around the tumor. Stimulated
acoustic emission signals within the ROI were automatically quantified
and expressed as particle-based color pixels in a ROI. The color pixels
within the three-dimensional ROI were counted and expressed as a per-
centage of the total number of pixels (color pixel density, CPD [%]).
Specificity of ICAM-1 Antibody– and RGD
Peptide–Conjugated Microbubbles
To demonstrate the specificity of the microbubbles, comparative
in vivo experiments were performed in one animal. The animal first re-
ceived ICAM-1 antibody–conjugatedmicrobubbles andwas scanned by
SPAQ. After imaging, it received 200 μg of “nonbiotinylated” ICAM-1
antibodies (Pharmingen) to block the target. Subsequently, ICAM-1
antibody–conjugated microbubbles were administered again, and their
accumulation within the tumor was investigated. The same procedure
Figure 1. SPAQ-based molecular imaging. (A) A rat with Dunning R3327-AT1 tumors implanted subcutaneously on both hind legs (white
arrows) was placed on an ultrasound gel pad. (B) An ultrasound transducer was fixed under the navigable table, which can be moved in
micrometer steps. The frame rate of the ultrasound Doppler system (25 Hz) was synchronized with the movement of the table (1.25 mm/
sec), resulting in an incremental move of 50 μm between the consecutive ultrasound pulses. (C) During the ultrasound scan, the targeted
microbubbles disintegrate and emit detectable signals (yellow dots within the tumor). The two-dimensional ultrasound images are recon-
structed to a three-dimensional data set that is quantitatively analyzed by an automatic video densitometry system.
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was performed with RGD-conjugated microbubbles and “nonbiotiny-
lated” RGD peptides (R&D Systems, Minneapolis, MN).
As additional negative controls, the animal receivedmicrobubbles con-
jugated to biotinylated mouse–antihuman immunoglobulin G (IgG)
control antibodies (antibodies-online GmbH, Aachen, Germany)
and to amino-terminal–biotinylated RAD peptides (Biotin-GRADSP;
Biomol GmbH, Hamburg, Germany). Their accumulation within the
tumor neovasculature was investigated and compared with the specific
microbubbles as well as with unconjugated microbubbles.
Immunohistochemistry
Three separate animals were killed for immunohistochemical analysis.
Irradiated and control tumors were removed surgically. Tumors were
frozen in liquid nitrogen vapor, cut in sections, and fixed by methanol/
acetone. Immunostaining was performed for CD31 (endothelial cells;
mouse-antirat CD31 IgG; Chemicon International, Temecula, CA),
CD61 (αvβ3-integrin; mouse-antirat CD61 IgG; Fitzgerald Industries
International, Concord, MA), and CD-54 (ICAM-1; mouse-antirat
CD54 IgG; BD Biosciences, San Jose, CA). A goat-antimouse IgG
antibody conjugated to Alexa Fluor 555 (Gentaur Molecular Prod-
ucts, Brussels, Belgium) served as secondary antibody. Cell nuclei were
counterstained by 4′,-6-diamidino-2-phenylindole (Invitrogen, Karlsruhe,
Germany). Tissue fluorescence sections were obtained. For the quantita-
tive analysis of fluorescence signals, area fractions with positive fluores-
cence were calculated. Ten representative area fractions were analyzed
from each tumor in the control and therapy groups.
Statistical Evaluation
Data are presented as mean ± SD. Differences in microbubble concen-
trations and vascularization between treated and untreated tumors were
compared using theMann-Whitney test (2-tailed). P < .05 was considered
significant. Statistical analysis was performed using GraphPadPrism 5.0
(GraphPad Software, San Diego, CA).
Results
Specificity of Targeted Mircobubbles
The concentrations of unspecific microbubbles as well as ICAM-1–
specific and αvβ3-integrin–specific microbubbles in tumors could be
quantified in vivo simultaneously (Figure 1) by destroying stationary
microbubbles through a volumetric high-powered Doppler ultrasound
scan. The number of voxels containing power Doppler signals was
normalized to the total number of voxels of the tumor volume to reveal
CPD values as a percentage (%).
In line with previous findings [14,17], specific microbubbles accumu-
lated significantly more intensely than unconjugated ones in all tumors
(P = .0006 for ICAM-1–specific and P = .01 for RGD-specific micro-
bubbles; Figure 2). In detail, the highest mean CPD in tumors was
found for ICAM-1–specific microbubbles (8.54 ± 3.98%; n = 8 tumors)
followed by αvβ3-integrin–specific microbubbles (5.11 ± 1.83%; n =
8 tumors). Nonconjugated microbubbles accumulated significantly less
intensely (2.96 ± 1.85%; n = 8 tumors).
Non–sense peptide–conjugated microbubbles and IgG control
antibody–conjugated microbubbles accumulated even less intensely
than unconjugated microbubbles with a free streptavidin coating. How-
ever, the difference in retention of uncoated, RAD non–sense peptide–
conjugated microbubbles (reduced by a factor of 0.8 compared with
unconjugated microbubbles), and IgG control antibody–conjugated
microbubbles (reduced by a factor of 0.75 compared with unconju-
gated microbubbles) was too small to reach statistical significance.
After administration of free ligands in excess (ICAM-1 antibodies
or RGD peptides), binding of specific microbubbles was reduced by
a factor of 0.71 for ICAM-1–specific microbubbles and by a factor
of 0.61 for αvβ3-integrin–specific microbubbles. Hence, competitive
blocking of the target could be demonstrated successfully in vivo.
To ensure that the signals counted did indeed originate from station-
ary targeted microbubbles rather than from blood flow or unbound
microbubbles within the blood pool, each scan was followed by three
control scans. Independent of the ligand that was bound to the micro-
bubbles, a significantly (P = .0002) lower CPD was found in the con-
trol scans (10.46 ± 4.42% during the first scan vs 2.05 ± 0.75%, 1.97 ±
0.74%, and 1.88 ± 0.75% during the consecutive control scans for
ICAM-1–conjugated microbubbles). In this context, the reproducibly
low concentration of microbubbles in the control scans indicates that
all site-targeted microbubbles were destroyed during the first diagnostic
scan using high-power sonication.
Tumor Monitoring after Carbon Ion Irradiation by
Functional and Molecular Ultrasound
To investigate whether changes in the expression of ICAM-1 or αvβ3-
integrin on tumor vessels can be assessed by molecular ultrasound,
tumors (n = 4) on the right hind leg of the animals were investigated
36 hours before and 36 hours after irradiation with carbon ions. Tumors
(n = 4) implanted on the left hind leg served as untreated controls.
Figure 2. Volumetric SPAQ measurements of entire tumors prove
the specificity of targetedmicrobubbles: After injection of unspecific
microbubbles, no relevant accumulation was observed within tumor
vessels. After administration of RGD-coated microbubbles targeted
against αvβ3-integrin, more Doppler signals (yellow dots) were visi-
ble, representing the bursting of stationary microbubbles at their
target. Quantitative analysis indicated significant accumulation com-
pared with unspecific microbubbles. Accumulation of anti–ICAM-1
antibody–coated microbubbles was even more pronounced (*P <
.05; **P < .01; n = 8 tumors).
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Tumor size. Before therapy, the mean size of tumors in the control
and therapy group did not differ significantly (212 ± 68 mm3 vs 272 ±
53 mm3, respectively). After 72 hours, the mean tumor volume in the
control group had increased by 120 ± 36%. In the therapy group, re-
tarded tumor growth with an increase of only 74 ± 38% was found.
Tumor vascularization. Vascularization of the tumors, as deter-
mined by volumetric high-frequency power Doppler ultrasound and
normalized to the initial value, indicated a comparable decrease in both
groups during tumor growth: In detail, the relative blood volume de-
creased from 100% to 55 ± 6% in the control group and from 100%
to 52 ± 15% in the therapy group.
Retention of αvβ3-integrin–specific microbubbles. Before treat-
ment, no significant difference was found between tumors in the control
and treatment groups with regard to retention of αvβ3-integrin–specific
microbubbles (control group: 6.78 ± 2.81% CPD; treatment group:
7.37 ± 1.26% CPD).
After 3 days, binding of αvβ3-integrin–specific microbubbles had
decreased in untreated controls to 57% of the original value (day 3:
3.91 ± 1.13% CPD). This decrease is in line with the general decrease
in vascularization during this time interval (decrease from 100% to
55 ± 6%; see previous paragraphs).
In irradiated tumors, however, binding of αvβ3-integrin–specific
microbubbles decreased to only 88% of the original value (day 3: 6.54 ±
1.23% CPD) despite a decrease in vascularization comparable to that
found in control tumors. The difference in the accumulation of αvβ3-
integrin–specific microbubbles between treated and untreated tumors
was significant, with higher values in the treatment group (P < .05).
Assuming that the general decrease inmicrobubble retention is some-
how related to the general decrease in vascularization, normalization
of microbubble accumulation to the relative blood volume was per-
formed. Although over time, normalized data on the accumulation
of αvβ3-integrin–specific microbubbles do not significantly change in
untreated control tumors, significantly increased values are found in
irradiated tumors, indicating up-regulation of this marker on the vas-
culature (P < .05; Figures 3 and 4).
Retention of ICAM-1–specific microbubbles. Before treatment,
no significant difference was found in the mean accumulated number
of stationary ICAM-1–specific microbubbles between tumors of the
control and treatment groups (control group: 19.49 ± 3.41% CPD;
treatment group: 15.38 ± 2.54% CPD).
After 3 days, binding of ICAM-1–specific microbubbles in the
untreated controls had significantly decreased to 38% of the original
value (day 3: 7.58 ± 3.79% CPD), most probably because of the de-
crease in vascularization during this time interval (decrease from 100%
to 55 ± 6%; see previous paragraphs). In treated tumors, however, bind-
ing of ICAM-1–specific microbubbles decreased to only 61% (day 3:
9.5 ± 4.48% CPD) despite the comparable decrease in vascularization.
Differences in the binding of ICAM-1–specific microbubbles in un-
treated and irradiated tumors were not significant. However, higher
values were found in treated tumors than in control ones, whereas at
the first examination time point, the opposite had been true.
Normalization of the concentration of ICAM-1–specific micro-
bubbles to the vascularization points to a down-regulation of this
marker at the vasculature of control tumors between the first and the
second examination time points (Figures 3 and 4).
Figure 3. Representative ultrasound images of irradiated and nonirradiated Dunning prostate tumors after injection of targeted microbubbles
using a three-dimensional destructive ultrasound technique (SPAQ [19]). Site-targetedmicrobubbles are color-coded as yellowDoppler signals.
(A and C) Retention of αvβ3-integrin–specific microbubbles is significantly lower in nonirradiated tumors (A) compared with irradiated ones (C;
*P < .05). (B and D) Accumulation of ICAM-1–specific microbubbles is lower in nonirradiated tumors (B) compared with irradiated ones (D).
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Carbon Ion Effects in Tumor Neovasculature in
Immunohistochemical Analysis
Quantitative analysis of immunofluorescence-positive area fractions
revealed that there are no significant differences in the expression of
CD31-positive vessels in untreated (2.47 ± 1.59% area fraction) and
irradiated (2.27 ± 1.15% area fraction) tumors. However, significantly
higher levels of CD61 (αvβ3-integrin) and CD54 (ICAM-1) were
observed in irradiated tumors. In detail, CD54-positive area fractions
were 0.17 ± 0.13% in irradiated tumors and 0.02 ± 0.01% in controls
(P < .01). Area fractions of CD61-positive staining were 0.07 ± 0.05%
Figure 4. Normalized data showed that retention of αvβ3-integrin–specific microbubbles was significantly increased in irradiated tumors,
indicating an up-regulation of this marker on tumor vessels. The normalized concentration of ICAM-1–specific microbubbles also increased
after irradiation, whereas decreasing values were found in untreated controls.
Figure 5. Immunofluorescence images of untreated and irradiated tumors showing cell nuclei stained with Hoechst (blue) and endo-
thelial cells stained with CD31 (red, upper column), αvβ3-integrin stained with CD61 (red, middle column), or ICAM-1 stained with CD54
(red, lower column). Quantification of the positive area fractions showed equal expression of CD31 in both groups, whereas CD61 and
CD54 were both significantly overexpressed in irradiated tumors. However, it must be mentioned that CD61 and CD54 are expressed
not only by endothelial cells but also by a certain number of tumor cells (**P < .01).
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in irradiated tumors and 0.01 ± 0.01% in controls (P < .01). How-
ever, one must consider that CD61 and CD54 are expressed not only
by endothelial cells but also, to some extent, by tumor cells as well.
Therefore, results from quantitative immunohistochemistry reflect the
overall up-regulation of CD61 and CD54 in treated tumors after irradia-
tion (Figure 5).
Discussion
Conventional radiotherapy is known to induce an up-regulation
of angiogenic marker molecules, which might allow adaptation of
complementary targeted treatment approaches [20]. This is the first
investigation of carbon ion radiation effects in experimental tumors
in vivo by noninvasive functional and molecular ultrasound imaging
with focus on the vascular changes.
On the basis of immunohistochemical analysis, we found that ex-
pression of the angiogenic marker αvβ3-integrin and expression of
the inflammatory maker ICAM-1 can both be induced by heavy ion
irradiation. We observed a general up-regulation of both markers on
angiogenic vessels and tumor cells. Moreover, changes in the expres-
sion of both markers on endothelial cells could be detected and quan-
tified by molecular ultrasound. However, to correctly interpret the
marker regulation, combined assessment of functional and molecular
data was required:
Functional ultrasound demonstrated a general decrease in vasculariza-
tion during 3 days of tumor growth, which affected both treated and
untreated tumors. We explain this finding as increased interstitial fluid
pressure at the center of the tumor and a loss in vessel functionality,
which are both known to occur during tumor growth [21,22]. Likewise,
retention of specific microbubbles decreased to an equal degree in con-
trol tumors. In irradiated tumors, the retention of specific microbubbles
also decreased but to a lower degree than in untreated controls. Tumors
treated with carbon ions showed a significantly higher retention of
αvβ3-integrin–specific microbubbles and a tendency to higher accumu-
lation of ICAM-1–specific microbubbles than in nonirradiated tumors.
To better examine the influence of changes in functional vascularization
on the accumulation of targeted microbubbles, we normalized the con-
centrations of stationary microbubbles to the relative blood volume.
The resulting data suggested that both markers are strongly upregulated
on the vasculature after irradiation, whereas unchanged or even lower
expression occurs in untreated tumors.
Combined assessment of the functional and molecular informa-
tion, as performed in our study, is required to draw conclusions about
whether the changing retention of microbubbles is related to a general
alteration in vascularization or to a real up- (or down-) regulation of
the markers by the endothelial cells. In most previous approaches,
information on vessel densities was derived from histologic measure-
ments of CD31-stained area fractions or was not available at all. For
example, histologic assessment of the vessel density in combination
with imaging of the molecular marker expression in tumor xenografts
during matrix metalloproteinase 2/9 inhibitor treatment has recently
been reported in an ultrasound study [14]. In contrast to this study,
which required invasive data to supplement the noninvasive imaging,
Ellegala et al. [23] reported on combined functional and molecular
ultrasound imaging during investigations on U87MG tumors in
rats. They observed an up-regulation of αvβ3-integrin during tumor
growth, which correlated to an increase in blood volume. Therefore,
the increasing marker densities seemed to reflect the general increase
in vessel surface. In contrast to these results, in the present study,
we observed, after carbon ion therapy, an up-regulation of the mark-
ers on the endothelium over time accompanied with strongly decreas-
ing vascularization.
Increased expression of αvβ3-integrin after irradiation has been re-
ported in other studies regarding the effects of x-ray irradiation on endo-
thelial cells [20]. However, little is known about the response of the
endothelium to carbon ions. Takahashi et al. [15] investigated the effects
of carbon irradiation on human umbilical vein endothelial cells. Inter-
estingly, they reported a down-regulation of αvβ3-integrin in contrast
with the reported effects of conventional radiotherapy. This observation
contrasts with the known effect of conventional radiotherapy [20]. How-
ever, the study was performed in vitro, and endothelial cells may behave
different in tumors or in a physiological matrix. In our in vivo setting,
we could clearly demonstrate an up-regulation of αvβ3-integrin on endo-
thelial cells by immunohistochemistry and targeted ultrasound within
a given time window of 36 hours after irradiation. The up-regulation
on the tumor cells themselves was assessable solely by immunohisto-
chemistry because ultrasound contrast agents are too large to leave the
vascular bed [11–13]. Consequently, targeted ultrasound imaging en-
ables the isolated detection of markers expressed on endothelial cells.
The second marker molecule investigated in our study was the
adhesion molecule ICAM-1. ICAM-1 plays a key role in cellular traffic
through the capillary wall, particularly during the inflammatory re-
sponse when leukocytes migrate from blood into tissues [24]. The
down-regulation of ICAM-1 in untreated control tumors indicates
a decrease in inflammation during a more advanced stage of our ex-
perimental prostate carcinomas. In contrast to the down-regulation
during growth, we found an up-regulation after irradiation. Inflamma-
tion is one of the major consequences of γ-radiation injury, and an up-
regulation of ICAM-1 after conventional irradiation has already been
reported in the literature [24]. However, for the first time, our results
indicate that the expression of the inflammation marker ICAM-1 is
also inducible by carbon ions. Therefore, imaging of ICAM-1 expres-
sion might be valuable in assessing therapy response or even for giving
an early indication of adverse effects (such as radionecrosis). The differ-
ence between conventional carbon ions is that conventional radiation
therapy uses photons, which are characterized by a low LET into
the irradiated tissue [5]. Although the net effect on cells in vitro and
in vivo in general is antiproliferative and proapoptotic, conventional
ionizing irradiation may trigger escape mechanisms with upregulated
proangiogenic surviving factors through integrins and receptor tyrosine
kinases. The combined approach of ionizing radiation with pharmaco-
logical antagonists of αvβ3-integrin efficiently suppresses angiogenesis
in several preclinical models [4,25,26]. One drug, the cyclic Arg-Gly-
Asp peptide Cilengitide (EMD121974) is presently undergoing clinical
evaluation alone and in combination with photon [7], supporting the
translational relevance of our studies.
In conclusion, carbon ion therapy induces an up-regulation of
ICAM-1 and αvβ3-integrin after irradiation, which can be assessed
noninvasively by three-dimensional molecular ultrasound. However,
changes in the vascular functionality that occur during tumor growth
require a combination of molecular imaging and assessment of the rela-
tive blood volume. In combination, the two methods can be used to
elucidate the dose- and time-dependent expression of multiple marker
molecules after heavy ion irradiation. It permits adaptation of the
therapy regimen to the molecular profile of tumors and their envi-
ronment and opens new perspectives for individualized timing of
combined anticancer therapies and treatment of irradiation-induced ad-
verse effects.
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